This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Kemia, a biotech active in the discovery and development of diverse oral small-molecule drug candidates, closed a $33.5mm Series B financing led by JP Morgan Partners. New investors were Novo AS and Hamilton Apex Technology. All Series A investors returned: Alta Partners, Forward Ventures, Texas Pacific Group, TPG Ventures, and Novartis BioVentures.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?